Regulation of ion transport and blood pressure by cytochrome p450 monooxygenases

Current Opinion in Nephrology and Hypertension

Volumn 16, Issue 5, 2007, Pages 465-470

  Capdevila, Jorge H ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

20 hydroxyeicosatetraenoic acid; Arachidonic acid monooxygenase; Epoxyeicosatrienoic acid; Epoxygenase; Hypertension; Ion channels

Indexed keywords

20 HYDROXYICOSATETRAENOIC ACID; ARACHIDONIC ACID DERIVATIVE; CYTOCHROME P450; EPOXYICOSATRIENOIC ACID; HEPOXILIN A; OXYGENASE; POTASSIUM CHANNEL;

BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; EARLY DIAGNOSIS; ELECTROPHYSIOLOGY; GENETIC VARIABILITY; HYPERTENSION; ION TRANSPORT; KIDNEY FUNCTION; MORBIDITY; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SODIUM EXCRETION;

ANIMALS; ARACHIDONIC ACID; BLOOD PRESSURE; CYTOCHROME P-450 ENZYME SYSTEM; EICOSAPENTAENOIC ACID; ELECTROPHYSIOLOGY; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; HYPERTENSION; ION TRANSPORT; IONS; KIDNEY; MODELS, BIOLOGICAL; SODIUM CHANNELS;

EID: 34547869872     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32827ab48c     Document Type: Review

References (59)

1. Nebert DW, Nelson DR, Coon MJ, et al. The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature. DNA Cell Biol 1991; 10:1-14.
2. Guengerich FP. Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 2006; 8:101-111; and cited references.
3. Cheng PY, Morgan ET. Hepatic cytochrome P450 regulation in disease states. Curr Drug Metab 2001; 2:165-183; and cited references.
4. Johnson EF, Hsu MH, Savas U, et al. Regulation of P450 4A expression by peroxisome proliferator activated receptors. Toxicology 2002; 181-182:203-206; and cited references.
5. Waxman DJ, O'Connor C. Growth hormone regulation of sex-dependent liver gene expression. Mol Endocrinol 2006; 20:2613-2629; and cited references.
6. Nebert DW, Dalton TP. The role of cytochrome P450 enzymes in endogenous signaling pathways and environmental carcinogenesis. Nat Rev Cancer 2006; 6:947-960; and cited references.
7. Capdevila JH, Falck JR, Harris RC. Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase. J Lipid Res 2000; 41:163-181; and cited references.
8. Capdevila JH, Falck JR. Biochemical and molecular properties of the cytochrome P450 arachidonic acid monooxygenases. Prostaglandins Other Lipid Mediat 2002; 68-69:325-344; and cited references.
9. Spector AA, Fang X, Snyder GD, et al. Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function. Prog Lipid Res 2004; 43:55-90; and cited references.
10. McGiff JC, Quilley J. 20-Hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr Opin Nephrol Hypertens 2001; 10:231-237; and cited references.
11. Roman RJ. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol Rev 2002; 82:131-185; and cited references.
12. Imig JD. Eicosanoids and renal vascular function in diseases. Clin Sci (Lond) 2006; 111:21-34; and cited references. A detailed analysis of the renovascular roles played by all the enzymes and metabolites of the arachidonate cascade.
13. Campbell WB, Falck JR. Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors. Hypertension 2007; 49:590-596.
14. Fleming I, Busse R. Endothelium-derived epoxyeicosatrienoic acids and vascular function. Hypertension 2006; 47:629-633.
15. Zeldin DC, Foley J, Ma J, et al. CYP2J subfamily P450s in the lung: expression, localization, and potential functional significance. Mol Pharmacol 1996; 50:1111-1117.
16. Lasker JM, Chen WB, Wolf I, et al. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney: role of Cyp4F2 and Cyp4A11. J Biol Chem 2000; 275:4118-4126.
17. Carroll MA, Schwartzman M, Sacerdoti D, et al. Novel arachidonate metabolites. Am J Med Sci 1988; 295:268-274.
18. Carroll MA, Schwartzman M, Capdevila J, et al. Vasoactivity of arachidonic acid epoxides. Eur J Pharmacol 1987; 138:281-283.
19. Proctor KG, Falck JR, Capdevila JH. Intestinal vasodilation by epoxyeicosatrienoic acids: arachidonic acid metabolites produced by a cytochrome P450 monooxygenase. Circ Res 1987; 60:50-59.
20. Gebremedhin D, Ma Y-H, Falck JR, et al. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol 1992; 263:H519-H525.
21. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur J Pharmacol 1993; 230:215-221.
22. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996; 78:415-423.
23. Feletou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 2006; 26:1215-1225.
24. + channel activity. Am J Physiol 1996; 270:F822-F832.
25. Fisslthaler B, Popp R, Kiss L, et al. Cytochrome P450 2C is an EDHF synthase in coronary arteries. Nature 1999; 401:493-496.
26. Scotland RS, Madhani M, Chauhan S, et al. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double knockout mice. Circulation 2005; 111:796-803.
27. Cohen RA. The endothelium-derived hyperpolarizing factor puzzle: a mechanism without a mediator? Circulation 2005; 111:724-727.
28. + channel. Circ Res 2006; 99:537-544. The first demonstration that disruption of a component of the EDHF system raises blood pressure.
29. 2+ permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium. Circ Res 2005; 97:908-915.
30. 2+ signaling complex with ryanodine receptors and BKCa channels. Circ Res 2005; 97:1270-1279.
31. Li P-L, Campbell WB. Epoxyeicosatrienoic acids activate potassium channels in coronary muscle through guanine nucleotide binding protein. Circ Res 1997; 80:877-884.
32. Gauthier KM, Deeter C, Krishna UM, et al. 14,15-Epoxyeicosa-5(Z)- enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 2002; 90:1028-1036.
33. Gauthier KM, Jagadeesh SG, Falck JR, et al. 14,15-Epoxyeicosa-5(Z) -enoicmSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries. Hypertension 2003; 42:555-561.
34. + channel in renal arterioles. Am J Physiol 1996; 270:R228-R237.
35. Imig JD, Falck JR, Wei S, et al. Epoxygenase metabolites contribute to the nitric oxide-independent afferent arteriolar vasodilation to bradykinin. J Vasc Res 2001; 38:247-255.
36. Imig JD, Zhao X, Falck JR, et al. Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonamide analog of 11,12-epoxyeicosatrienoic acid. J Hypertens 2001; 19:983-992.
37. Wang MH, Guan H, Nguyen X, et al. Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys. Am J Physiol 1999; 276:F246-F253.
38. Chen YF, Meng QC. Sexual dimorphism of blood pressure in spontaneously hypertensive rats is androgen dependent. Life Sci 1991; 48:85-96; and cited references.
39. Holla VR, Adas F, Imig JD, et al. Alterations in the regulation of androgensensitive Cyp 4a monooxygenases cause hypertension. Proc Natl Acad Sci U S A 2001; 98:5211-5216.
40. Jacobson HR, Corona S, Capdevila JH, et al. Effects of epoxyeicosatrienoic acids on ion transport in the rabbit cortical collecting tubule. In: Braquet P, Frolich JC, Nicosia S, Garay R, editors. Prostaglandins and membrane ion transport. New York: Raven Press; 1984. pp. 311-318.
41. Holla VR, Makita K, Zaphiropoulus PG, et al. The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading. J Clin Invest 1999; 104:751-760.
42. Makita K, Takahashi K, Karara A, et al. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest 1994; 94:2414-2420.
43. Nakagawa K, Holla VR, Wei Y, et al. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel. J Clin Invest 2006; 116:1696-1702. Unequivocal evidence that cytochrome P450s participate in the regulation of sodium and water balance, and systemic blood pressure.
44. Wei Y, Lin DH, Kemp R, et al. Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase dependent pathways. J Gen Physiol 2004; 124:719-727.
45. Lifton RP, Gharavi AG, Geller DS. Molecular mechanisms of human hypertension. Cell 2001; 104:545-556; and cited references.
46. Schild L, Schneeberger E, Gautschi I, et al. Identification of amino acid residues in the alpha, beta, and gamma subunits of the epithelial sodium channel (ENaC) involved in amiloride block and ion permeation. J Gen Physiol 1997; 109:15-26.
47. Gainer JV, Bellamine A, Dawson EP, et al. A functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension. Circulation 2005; 111:63-69.
48. Mayer B, Lieb WQ, Gotz A, et al. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg Echocardiographic Substudy. Hypertension 2005; 46:766-771.
49. Laffer CL, Laniado-Schwartzman M, Wang MH, et al. Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension. Circulation 2003; 107:574-578.
50. Michaelis UR, Fleming I. From endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: epoxyeicosatrienoic acids (EETs) and cell signaling. Pharmacol Ther 2006; 111:584-595; and cited references.
51. Neylon CB. Potassium channels and vascular proliferation. Vasc Pharmacol 2002; 38:35-41.
52. + channels in regulating tumor cell proliferation and apoptosis. Eur J Physiol 2004; 448:274-286; and cited references.
53. Pardo LA. Voltage-gated potassium channels in cell proliferation. Physiol 2004; 19:285-292; and cited references.
54. Miguel-Velado E, Moreno-Dominguez A, Colinas O, et al. Contribution of Kv channels to phenotypic remodeling of human uterine artery smooth muscle cells. Cir Res 2005; 1280-1287.
55. Wong PY-K, Lai P-S, Falck JR. Mechanism and signal transduction of 14(R), 15(S)-epoxyeicosatrienoic acid (14,15-EET) binding in guinea pig monocytes. Prostag Other Lipid Med 2000; 62:321-333.
56. Chen JK, Wang DW, Falck JR, et al. Transfection of an active cytochrome P450 arachidonic acid epoxygenase indicated that 14,15- epoxyeicosatrienoic acid functions as an intracellular second messenger in response to epidermal growth factor. J Biol Chem 1999; 274:4764-4769.
57. Chen JK, Falck JR, Reddy KM, et al. epoxyeicosatrienoic acids and their sulfonimide derivatives stimulate tyrosine phosphorylation and induce mitogenesis in renal epithelial cells. J Biol Chem 1998; 273:29254-29261.
58. Ca channels. Am J Physiol 1998; 275:L423-L431.
59. Chen J, Capdevila JH, Zeldin DC, Rosenberg RL. Inhibition of L-type calcium channels by epoxyeicosatrienoic acids. Mol Pharmacol 1999; 55:288-295.